Use of urine neutrophil gelatinase-associated lipocalin for nephrotoxic medication acute kidney injury screening in neonates

Cara L. Slagle,Trina Hemmelgarn,Hailey W. Gavigan,Kelli A. Krallman,Stuart L. Goldstein
DOI: https://doi.org/10.1038/s41372-024-01922-6
2024-03-22
Journal of Perinatology
Abstract:Daily serum creatinine monitoring protocols for acute kidney injury (AKI) are invasive and may lead to surveillance resistance. We aimed to understand if use of urine neutrophil gelatinase-associated lipocalin (uNGAL) could increase high-risk nephrotoxic medication (NTMx) associated AKI screening adherence in neonates.
pediatrics,obstetrics & gynecology
What problem does this paper attempt to address?